索拉非尼引起的间质性肉芽肿性药物反应。 - Suppr

Interstitial granulomatous drug reaction to sorafenib.

作者信息

Martínez-Morán Cristina, Nájera Laura, Ruiz-Casado Ana I, Romero-Maté Alberto, Espinosa Pablo, Meseguer-Yebra Carmen, Córdoba Susana, Borbujo Jesús M

出版信息

Arch Dermatol. 2011 Sep;147(9):1118-9. doi: 10.1001/archdermatol.2011.241.

DOI:10.1001/archdermatol.2011.241

PMID:21931061

Abstract

摘要

相似文献

Interstitial granulomatous drug reaction to sorafenib.

Arch Dermatol. 2011 Sep;147(9):1118-9. doi: 10.1001/archdermatol.2011.241.

[Palmoplantar cutaneous reaction to sorafenib].

Actas Dermosifiliogr. 2009 Oct;100(8):736-7.

Severe sorafenib-induced hand-foot skin reaction.

Dermatol Online J. 2011 May 15;17(5):14.

Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.

Br J Dermatol. 2008 Mar;158(3):592-6. doi: 10.1111/j.1365-2133.2007.08357.x. Epub 2007 Dec 6.

[Dermatologic toxicity to sorafenib].

Actas Dermosifiliogr. 2009 Jul-Aug;100(6):518-20.

Perforating folliculitis, angioedema, hand-foot syndrome--multiple cutaneous side effects in a patient treated with sorafenib.

J Dtsch Dermatol Ges. 2009 May;7(5):449-52. doi: 10.1111/j.1610-0387.2009.07017.x. Epub 2009 Jan 29.

Successful topical treatment of sorafenib-induced hand-foot skin reaction in a child with hepatocellular carcinoma.

Pediatr Dermatol. 2009 May-Jun;26(3):349-50. doi: 10.1111/j.1525-1470.2009.00933.x.

Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.

Dermatol Ther. 2011 Jul-Aug;24(4):396-400. doi: 10.1111/j.1529-8019.2011.01435.x.

Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.

Arch Dermatol. 2008 Jul;144(7):886-92. doi: 10.1001/archderm.144.7.886.

Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.

Oncology. 2009;77(5):257-71. doi: 10.1159/000258880. Epub 2009 Nov 16.

引用本文的文献

Granulomatous Cutaneous Drug Eruptions: A Systematic Review.

Am J Clin Dermatol. 2021 Jan;22(1):39-53. doi: 10.1007/s40257-020-00566-4.

A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report.

SAGE Open Med Case Rep. 2018 Sep 10;6:2050313X18795075. doi: 10.1177/2050313X18795075. eCollection 2018.

Interstitial granulomatous dermatitis successfully treated with etanercept.

Am J Case Rep. 2014 Mar 1;15:94-6. doi: 10.12659/AJCR.890074. eCollection 2014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Interstitial granulomatous drug reaction to sorafenib.

作者信息

Martínez-Morán Cristina, Nájera Laura, Ruiz-Casado Ana I, Romero-Maté Alberto, Espinosa Pablo, Meseguer-Yebra Carmen, Córdoba Susana, Borbujo Jesús M

出版信息

Arch Dermatol. 2011 Sep;147(9):1118-9. doi: 10.1001/archdermatol.2011.241.

DOI:10.1001/archdermatol.2011.241

PMID:21931061

Abstract

摘要

相似文献

Interstitial granulomatous drug reaction to sorafenib.

Arch Dermatol. 2011 Sep;147(9):1118-9. doi: 10.1001/archdermatol.2011.241.

[Palmoplantar cutaneous reaction to sorafenib].

Actas Dermosifiliogr. 2009 Oct;100(8):736-7.

Severe sorafenib-induced hand-foot skin reaction.

Dermatol Online J. 2011 May 15;17(5):14.

Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.

Br J Dermatol. 2008 Mar;158(3):592-6. doi: 10.1111/j.1365-2133.2007.08357.x. Epub 2007 Dec 6.

[Dermatologic toxicity to sorafenib].

Actas Dermosifiliogr. 2009 Jul-Aug;100(6):518-20.

Perforating folliculitis, angioedema, hand-foot syndrome--multiple cutaneous side effects in a patient treated with sorafenib.

J Dtsch Dermatol Ges. 2009 May;7(5):449-52. doi: 10.1111/j.1610-0387.2009.07017.x. Epub 2009 Jan 29.

Successful topical treatment of sorafenib-induced hand-foot skin reaction in a child with hepatocellular carcinoma.

Pediatr Dermatol. 2009 May-Jun;26(3):349-50. doi: 10.1111/j.1525-1470.2009.00933.x.

Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.

Dermatol Ther. 2011 Jul-Aug;24(4):396-400. doi: 10.1111/j.1529-8019.2011.01435.x.

Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.

Arch Dermatol. 2008 Jul;144(7):886-92. doi: 10.1001/archderm.144.7.886.

Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.

Oncology. 2009;77(5):257-71. doi: 10.1159/000258880. Epub 2009 Nov 16.

引用本文的文献

Granulomatous Cutaneous Drug Eruptions: A Systematic Review.

Am J Clin Dermatol. 2021 Jan;22(1):39-53. doi: 10.1007/s40257-020-00566-4.

A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report.

SAGE Open Med Case Rep. 2018 Sep 10;6:2050313X18795075. doi: 10.1177/2050313X18795075. eCollection 2018.

Interstitial granulomatous dermatitis successfully treated with etanercept.

Am J Case Rep. 2014 Mar 1;15:94-6. doi: 10.12659/AJCR.890074. eCollection 2014.

Interstitial granulomatous drug reaction to sorafenib.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Interstitial granulomatous drug reaction to sorafenib.

作者信息

出版信息

相似文献

引用本文的文献